The ESSO core curriculum committee update on surgical oncology.

Jelle Ruurda, Tessa van Ginhoven, Santiago Gonzalez-Moreno, Jos van der Hage, Merlijn Hutteman, Yazan Masannat, Elisa Concetta Onesti, Beate Rau, Theo De Reijke, Isabel Rubio, Marco Fiore, Sergio Sandrucci, Kjetil Soreide, Stefan Stattner, Dario Trapani, Domenico D'Ugo, Menno Vriens, Lynda Wyld, Ane Gerda Zahl Eriksson, Kim Benstead, Sergio Sandrucci, Riccardo Audisio, Lynda Wyld, Kjetil Søreide, Teresa Amaral, Riccardo Audisio, Viren Bahadoer, Geerard Beets, Jos van der Hage, Elisabeth Berge Nilsen, Kalijn Bol, Andreas Brandl, Jerry Braun, Tanja Cufer, Cristina Dopazo, Ibrahim Edhemovic, Jesper Grau Eriksen

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022;47(11):e1-e30

PMID: 34657781

Abstract

INTRODUCTION

Surgical oncology is a defined specialty within the European Board of Surgery within the European Union of Medical Specialists (UEMS). Variation in training and specialization still occurs across Europe. There is a need to align the core knowledge needed to fulfil the criteria across subspecialities in surgical oncology.

MATERIAL AND METHODS

The core curriculum, established in 2013, was developed with contributions from expert advisors from within the European Society of Surgical Oncology (ESSO), European Society for Radiotherapy and Oncology (ESTRO) and European Society of Medical Oncology (ESMO) and related subspeciality experts.

RESULTS

The current version reiterates and updates the core curriculum structure needed for current and future candidates who plans to train for and eventually sit the European fellowship exam for the European Board of Surgery in Surgical Oncology. The content included is not intended to be exhaustive but, rather to give the candidate an idea of expectations and areas for in depth study, in addition to the practical requirements. The five elements included are: Basic principles of oncology; Disease site specific oncology; Generic clinical skills; Training recommendations, and, lastly; Eligibility for the EBSQ exam in Surgical Oncology.

CONCLUSIONS

As evidence-based care for cancer patients evolves through research into basic science, translational research and clinical trials, the core curriculum will evolve, mature and adapt to deliver continual improvements in cancer outcomes for patients.

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Address: Department of Surgery, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands. Electronic address: [email protected].; Surgical Oncology Unit, City of Health and Science, University of Turin, Turin, Italy.; Department of Surgery, Sahlgrenska University Hospital, University of Gothenburg, Sweden.; Department of Oncology and Metabolism, Sheffield University, Sheffield, United Kingdom.; Department of Gastrointestinal Surgery, HPB unit, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. Electronic address: [email protected].; Dermatology, Eberhard Karls Universitat Tubingen, Tubingen, Germany.; University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Gloucestershire Oncology Centre, Cheltenham General Hospital, United Kingdom.; Department of Obstetrics and Gynecology, Stavanger University Hospital, Stavanger, Norway.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Surgery, Campus Virchow-Klinikum and Charité Campus Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany; Digestive Unit, Champalimaud Foundation, Lisbon, Portugal.; Department of Thoracic Surgery, Leiden University Medical Center, Leiden, the Netherlands.; University Clinic Golnik, University of Ljubljana, 4204 Ljubljana, Slovenia.; Department of Hepato-Pancreato-Biliary and Transplant Surgery, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Surgery, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Anderson Cancer Center, Madrid, Spain.; University of Aberdeen, School of Medicine, Medical Science and Nutrition, Aberdeen, UK.; Department of Clinical and Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.; Department of General Surgery, Charité University of Berlin, Berlin, Germany.; Department of Urology, Amsterdam UMC, Amsterdam, the Netherlands.; Breast Surgical Oncology, Clínica Universidad de Navarra, Madrid, Universidad de Navarra, Spain.; Visceral Sarcoma Surgery Unit, Città della Salute e della Scienza, Turin, Italy.; Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway.; Department of Surgery, Salzkammergutklinikum, Standort Vöcklabruck, Oberösterreich, Austria.; Department of Surgery, Paracelsus Medical University Salzburg, Salzburg, Austria; New drugs development for innovative therapies, European Institute of Oncology, IRCCS, Milano, Italy.; General Surgery Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University, 00168 Rome, Italy.; Department of Surgery, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; Gynecologic Oncology, NSGO, Universitetet i Oslo, Oslo, Norway.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.